Summary
- Current Price
- As of today, KYMR price is $77.94, down -1.52% in the most recent trading session on
- Current Price All-Time High
- KYMR price is currently -24.33% below its historical high of $103.00 set on
- Market Cap
- KYMR current market cap is $6B, up +183.46% over the past 365 days
- PE Ratio
- KYMR PE ratio is unknown
- Revenue
- KYMR current annual revenue is $39.21M, down -16.70% year-over-year
- Next Earnings
- The next earnings release for KYMR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kymera Therapeutics, Inc. |
| Ticker | NASDAQ: KYMR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kymeratx.com |
| Employees | 208 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $77.94 | |
| Price, 1D Change | -1.52% | |
| $6B | ||
| - | ||
| - | ||
| 1.40 | ||
| $39M | ||
| Revenue, 1Y Change | -16.70% | |
| -$3.69 | ||
| EPS, 1Y Change | -23.53% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.69 | ||
| EPS Estimate | N/A | -$3.60 |
| EPS Est. Change | N/A | +2.27% |
| $39.21M | ||
| Revenue Estimate | N/A | $40.09M |
| Revenue Est. Change | N/A | +2.24% |
| Current Price | $77.94 | |
| Price Target | - | $120.00 |
| Price Tgt. Change | - | +53.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$2.98 | -5.06% | |
| -$3.47 | -$3.69 | -6.32% | |
| -$3.60 | N/A | +2.27% | |
| -$4.02 | N/A | -9.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $53.83M | $47.07M | -12.55% | |
| $53.64M | $39.21M | -26.90% | |
| $40.09M | N/A | +2.24% | |
| $41.44M | N/A | +5.69% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $77.94 | |
| $61.27 | ||
| SMA 200 vs Price | -21.39% | |
| $79.53 | ||
| SMA 50 vs Price | +2.03% | |
| 1.40 | ||
| $4.22 | ||
| 43.10 | ||
| 40.51% | ||
| 82.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $39.21M | ||
| -$3.69 | ||
| $0.00 | ||
| 78.80% | ||
| -$345.54M | ||
| -881.24% | ||
| -$311.35M | ||
| -794.04% | ||
| -$337.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 10.47 | ||
| 10.47 | ||
| - | ||
| 3 | ||
| 22.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 159.02 | ||
| 3.95 | ||
| -16.22 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.58B | ||
| $848.28M | ||
| $1.74B | ||
| $871.21M | ||
| $163.15M | ||
| $83.21M | ||
| $82.25M | ||
| $13.76M | ||
| $4.02M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $350.56M | ||
| $376.44M | ||
| $8.31M | ||
| $68.19M | ||
| $8.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$232.89M | ||
| -$521.06M | ||
| $990.71M | ||
| $1.45M | ||
| -$234.34M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| Stephens & Co. | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| BTIG | → | |
| BTIG | → | |
| Barclays | → | |
| BTIG | → | |
| Wolfe Research | → | |
| B. Riley Securities | → |
Analyst sentiment
Institutional ownership
Screeners with KYMR
FAQ
What is the ticker symbol for Kymera Therapeutics, Inc.?
The ticker symbol for Kymera Therapeutics, Inc. is NASDAQ:KYMR
Does Kymera Therapeutics, Inc. pay dividends?
No, Kymera Therapeutics, Inc. does not pay dividends
What sector is Kymera Therapeutics, Inc. in?
Kymera Therapeutics, Inc. is in the Healthcare sector
What industry is Kymera Therapeutics, Inc. in?
Kymera Therapeutics, Inc. is in the Biotechnology industry
What country is Kymera Therapeutics, Inc. based in?
Kymera Therapeutics, Inc. is headquartered in United States
When did Kymera Therapeutics, Inc. go public?
Kymera Therapeutics, Inc. initial public offering (IPO) was on August 21, 2020
Is Kymera Therapeutics, Inc. in the S&P 500?
No, Kymera Therapeutics, Inc. is not included in the S&P 500 index
Is Kymera Therapeutics, Inc. in the NASDAQ 100?
No, Kymera Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Kymera Therapeutics, Inc. in the Dow Jones?
No, Kymera Therapeutics, Inc. is not included in the Dow Jones index
When was Kymera Therapeutics, Inc. last earnings report?
Kymera Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Kymera Therapeutics, Inc. report earnings?
The next expected earnings date for Kymera Therapeutics, Inc. is May 8, 2026
Data Sources & References
- KYMR Official Website www.kymeratx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1815442/000119312526073395/0001193125-26-073395-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1815442/000119312526073395/0001193125-26-073395-index.htm
- KYMR Profile on Yahoo Finance finance.yahoo.com/quote/KYMR
- KYMR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kymr